Conference Coverage
Conference Coverage
Affording the cost of new obesity drugs? We can’t afford not to
“Patient happiness and self-esteem are hard to measure and capture as cost impacts. We need to also add carbon dioxide effects and transportation...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
Conference Coverage
Setmelanotide offers significant, long-lasting weight loss
Melanotide is being tested with respect to other mutations responsible for severe obesity, raising hopes that it will soon be indicated for use in...
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
Conference Coverage
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
Conference Coverage
Education before Ramadan key to safe fasting with diabetes
“With correct advice and support” from knowledgeable health care professionals “most people with type 2 diabetes can fast safely during Ramadan...
Conference Coverage
COORDINATE-Diabetes: A ‘wake-up call’ for many specialties
“I look at COORDINATE as a wake-up call to the need for multispecialty approaches to people with type 2 diabetes and cardiovascular disease.”
Conference Coverage
‘Artificial pancreas’ for all type 1 diabetes pregnancies?
The hybrid closed-loop system is not available in the United States but other systems are available and sometimes used off label in pregnancy.
Conference Coverage
Survodutide impresses in phase 2 weight loss trial
Survodutide has received U.S. Food and Drug Administration Fast Track Designation for adults with NASH.
Conference Coverage
Thirty-three percent of type 1 diabetes patients insulin free with stem cells
Engraftment of Vertex Pharmaceutical’s VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent...
Latest News
Residency match process under scrutiny again, this time by AMA
AMA may study alternatives to the current residency matching program in an effort to improve residents’ compensation and other job-related issues...